MEDIMAGING INTEGRATED SOLUTION INC. Financials Medimaging Integrated Solution Inc.
Equities
6796
TW0006796006
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 81.8 TWD | +0.12% |
|
+0.62% | -24.95% |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 2,019 | 2,379 | 3,770 |
| Enterprise Value (EV) 1 | 1,916 | 2,132 | 3,516 |
| P/E ratio | 29.8 x | 33.1 x | 50 x |
| Yield | 2.63% | 2.51% | 1.65% |
| Capitalization / Revenue | 4.16 x | 4.74 x | 7.02 x |
| EV / Revenue | 3.94 x | 4.25 x | 6.55 x |
| EV / EBITDA | 16.6 x | 24.9 x | 29.5 x |
| EV / FCF | 127,196,589 x | 74,456,840 x | -78,171,584 x |
| FCF Yield | 0% | 0% | -0% |
| Price to Book | 4.15 x | 3.67 x | 4.76 x |
| Nbr of stocks (in thousands) | 30,006 | 33,228 | 34,584 |
| Reference price 2 | 67.30 | 71.60 | 109.0 |
| Announcement Date | 4/13/22 | 3/30/23 | 3/25/24 |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 367.9 | 314.5 | 402.5 | 485.9 | 502.1 | 537.1 |
| EBITDA 1 | 79.39 | 25.8 | 88.83 | 115.4 | 85.58 | 119.4 |
| EBIT 1 | 68.02 | 5.698 | 64.83 | 86.62 | 59.6 | 91.92 |
| Operating Margin | 18.49% | 1.81% | 16.11% | 17.83% | 11.87% | 17.11% |
| Earnings before Tax (EBT) 1 | 74.61 | 5.042 | 60.23 | 80.91 | 87.41 | 92.98 |
| Net income 1 | 58.6 | 4.783 | 54.12 | 66.48 | 70.02 | 74.05 |
| Net margin | 15.93% | 1.52% | 13.45% | 13.68% | 13.95% | 13.79% |
| EPS 2 | 2.024 | 0.1667 | 1.873 | 2.260 | 2.160 | 2.180 |
| Free Cash Flow | - | -58.48 | -11.6 | 15.06 | 28.63 | -44.98 |
| FCF margin | - | -18.59% | -2.88% | 3.1% | 5.7% | -8.37% |
| FCF Conversion (EBITDA) | - | - | - | 13.06% | 33.45% | - |
| FCF Conversion (Net income) | - | - | - | 22.66% | 40.89% | - |
| Dividend per Share 2 | 1.667 | 0.1587 | 1.270 | 1.770 | 1.797 | 1.800 |
| Announcement Date | 8/7/20 | 8/7/20 | 3/31/21 | 4/13/22 | 3/30/23 | 3/25/24 |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 Q1 | 2022 Q2 | 2022 Q3 |
|---|---|---|---|
| Net sales 1 | 113.3 | 115.5 | 121.1 |
| EBITDA | - | - | - |
| EBIT 1 | 7.506 | 12.98 | 11.83 |
| Operating Margin | 6.62% | 11.24% | 9.77% |
| Earnings before Tax (EBT) | - | - | - |
| Net income | - | - | - |
| Net margin | - | - | - |
| EPS | - | - | - |
| Dividend per Share | - | - | - |
| Announcement Date | 5/13/22 | 8/11/22 | 11/10/22 |
1TWD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 161 | 37.1 | 48.5 | 104 | 247 | 253 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow | - | -58.5 | -11.6 | 15.1 | 28.6 | -45 |
| ROE (net income / shareholders' equity) | - | 1.33% | 14.9% | 15.2% | 12.3% | 10.3% |
| ROA (Net income/ Total Assets) | - | 0.71% | 7.23% | 8.12% | 4.78% | 5.27% |
| Assets 1 | - | 678.2 | 748.5 | 819.2 | 1,464 | 1,406 |
| Book Value Per Share 2 | 13.70 | 11.90 | 13.80 | 16.20 | 19.50 | 22.90 |
| Cash Flow per Share 2 | 7.370 | 4.700 | 6.150 | 7.470 | 8.280 | 13.70 |
| Capex 1 | 107 | 33.6 | 38 | 26.3 | 49.9 | 191 |
| Capex / Sales | 29.1% | 10.68% | 9.43% | 5.41% | 9.94% | 35.65% |
| Announcement Date | 8/7/20 | 8/7/20 | 3/31/21 | 4/13/22 | 3/30/23 | 3/25/24 |
1TWD in Million2TWD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -24.95% | 87.75M | |
| +73.17% | 12.39B | |
| -19.99% | 7.89B | |
| +8.84% | 6.59B | |
| +13.24% | 5.43B | |
| +40.80% | 4.96B | |
| -17.34% | 4.72B | |
| -18.76% | 4.02B | |
| -29.16% | 2.66B | |
| +61.25% | 2.37B |
- Stock Market
- Equities
- 6796 Stock
- Financials Medimaging Integrated Solution Inc.
